Polymorphisms in the TNF-α and TNF-receptor genes in patients with coronary artery disease

European Journal of Clinical Investigation

Volumn 31, Issue 10, 2001, Pages 843-851

  Allen, R A ^a,b   Lee, E M ^a   Roberts, D H ^a   Park, B K ^b   Pirmohamed, M ^b  

^a BLACKPOOL VICTORIA HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Atherosclerosis; Coronary artery disease; Genetics; TNF

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; AGED; ALLELES; ANTIGENS, CD; BASE SEQUENCE; CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; DNA; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035740311     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2001.00907.x     Document Type: Article

References (46)

1. Genetic susceptibility to death from coronary artery disease in a study of twins
2. Molecular genetics as the route to understanding, prevention and treatment
3. Coronary heart disease and genetics: And epidemiologists view
4. Atherosclerosis - And inflammatory disease
5. Detection and localisation of tumor necrosis factor in human atheroma
6. Increased secretion of tumor necrosis factor-α and interferon-γ by mononuclear leukocytes in patients with ischaemic heart disease
7. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxaemia and function simultaneously as both TNF carriers and TNF antagonists
8. A physiochemical modelling approach for estimating the stability of soluble receptor-bound tumour necrosis factor-alpha
9. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure
10. Heritable major histocompatability complex class II-associated differences in production of tumor necrosis factor-α: Relevance to genetic predisposition to systemic lupus erythematosus
11. Effects of a polymorphism in the human tumor necrosis factor-α promoter on transcriptional activation
12. Gene polymorphism at position -308 of the tumor necrosis factor-α (TNF-α) in multiple sclerosis and its influence on the regulation of TNFα production
13. The -308 tumor necrosis factor-α promoter polymorphism effects transcription
14. TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients
15. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
16. Polymorphism in tumor necrosis factor-α genes associated with mucocutaneous leishmaniasis
17. Tumor necrosis factor-alpha gene polymorphisms in psoriasis
18. A TNF-α promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis
19. Genetic variants in the tumor necrosis factor receptor 1 gene in patients with MS
20. Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus
21. Polymorphisms of tumor necrosis factor receptor 2 are not associated with insulin-dependent diabetes mellitus or Graves disease
22. Tumor necrosis factor receptor II (TNFRII) exon 6 polymorphism in systemic lupus erythematosus
23. A simple salting out procedure for extracting DNA from human nucleated cells
24. Single base polymorphism in human tumor necrosis factor alpha (TNF-α) gene detectable by Nco1 restriction of PCR product
25. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis
26. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease
27. -308→A polymorphism and risk for coronary artery disease
28. Polymorphisms of the tumor necrosis factor-α gene, coronary heart disease and obesity
29. The immunogenetics of human infectious disease
30. Tumour necrosis factor haplotypes and asthma
31. Molecular genetics of coronary artery disease: Measuring the phenotype
32. Detection of a C insertion polymorphism within the human tumor necrosis factor alpha (TNF-α) gene
33. Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men
34. -308 Tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter
35. Secretion of tumour necrosis factor-α and lymphotoxin-α in relation to polymorphisms in the TNF genes and HLA DR alleles. Relevance for inflammatory bowel disease
36. Different transcriptional activity and in vitro TNF-α production in psoriasis patients carrying the TNF-α238A promoter polymorphism
37. Functional analysis of a new polymorphism in the human TNF-α gene promoter
38. An allelic polymorphism within the human tumor necrosis factor-α promoter region is strongly associated with HLA A1, B8 and DR3 alleles
39. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria
40. A common functional polymorphism (C→A substitution at position - 863) in the promoter region of the tumour necrosis factor-α (TNF-α) gene associated with reduced circulating levels of TNF-α
41. Increased monocyte TNF-α message stability contributes to trauma patients increased TNF production
42. Genomic organization and promoter function of the murine tumor necrosis factor receptor beta gene
43. Modulation of the constitutive gene expression of the 55 kD tumor necrosis factor receptor in hematopoietic cells
44. TNF induces internalization of the p60 receptor and shedding of the p80 receptor
45. T lymphocytes from human atherosclerotic plaques recognise oxidised low density lipoprotein
46. Association of Helicobacter pylori and chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors